Polyisoprenylated Benzophenone Composition for Adipogenesis Inhibition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack an effective, safe, and natural approach to inhibit adipogenesis for managing obesity, which is a growing global health issue associated with various chronic and psychological problems.
Innovation Solution
A composition comprising polyisoprenylated benzophenone derivatives, such as garcinol/guttiferones, combined with stilbene derivatives like pterostilbene and anthocyanins, which inhibits adipogenesis and is formulated into various dosage forms for treating obesity or weight loss.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If natural compounds like garcinol, pterostilbene, and anthocyanins are used to inhibit adipogenesis, then safety and natural approach are improved, but effectiveness in treating obesity is insufficient when used individually
Solution Approach 1:
The patent combines three natural compounds (garcinol, pterostilbene, and anthocyanins) into a single composition to achieve synergistic effects. The combination formula of 5:3:2 (garcinol:pterostilbene:anthocyanins) was determined to provide enhanced adipogenesis inhibition compared to individual compounds, resolving the contradiction between safety and effectiveness by merging multiple safe natural compounds.
Solution Approach 2:
The invention creates a composite pharmaceutical composition integrating multiple natural compounds with complementary mechanisms of action. This composite approach allows each compound to contribute its unique properties while working together to achieve superior anti-obesity effects, maintaining safety while enhancing productivity.
2Productivity
If a combination of multiple natural compounds is used to enhance adipogenesis inhibition, then effectiveness is improved, but formulation complexity increases
Solution Approach 1:
The patent optimizes the formulation by establishing specific concentration ratios (5:3:2) and dosage parameters for the compound combination. By defining precise parameter ranges and optimal values, the invention simplifies the formulation process while maintaining enhanced effectiveness, resolving the contradiction between productivity improvement and complexity increase.
Data Source
AI summary
The present invention provides a composition comprising polyisoprenylated benzophenone derivative and at least one component selected from stilbene derivative and anthocyanins. The composition inhibits adipogenesis and is therefore useful in treating obesity or weight loss.